NEO Competitors & Alternatives
Compare NeoGenomics Inc with similar stocks in the same industry
Diagnostics & Research
NEO
Main Stock$15.16
Tradestie Score
57
Market Cap
$1.13B
Revenue Growth
0.1%
Analyst Upside
-0.7%
Top Competitors
36 stocks in Diagnostics & Research| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
VCYT
Veracyte, Inc.
|
$57.08
|
$2.85B | 55.4 | 62 | Compare |
|
GRAL
GRAIL, Inc. Common Stock
|
$69.11
|
$2.24B | - | 59 | Compare |
|
ADPT
Adaptive Biotechnologies Corporation Common Stock
|
$21.19
|
$2.22B | - | 64 | Compare |
|
TWST
Twist Bioscience Corporation Common Stock
|
$99.24
|
$1.77B | - | 54 | Compare |
|
NVCR
NovoCure Limited Ordinary Shares
|
$17.20
|
$1.56B | - | 57 | Compare |
|
NEOG
Neogen Corp
|
$9.34
|
$1.26B | - | 62 | Compare |
|
OPK
Opko Health Inc.
|
$1.52
|
$1.23B | - | 55 | Compare |
|
CDNA
CareDx, Inc.
|
$29.19
|
$798.40M | - | 55 | Compare |
|
FLGT
Fulgent Genetics, Inc. Common Stock
|
$20.85
|
$719.31M | - | 58 | Compare |
|
MYGN
Myriad Genetics Inc
|
$5.99
|
$719.23M | - | 50 | Compare |
More NEO Analysis
Data updated: Jul 02, 2026 | Industry: Diagnostics & Research (SIC 8734)
36 stocks in this industry